Dr. Rettig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Department of Medicine/Division of Hem-Onc
11301 Wilshire Blvd., 111H
Los Angeles, CA 90073Phone+1 310-268-3622Fax+1 310-268-3622- Is this information wrong?
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996
University of WashingtonResidency, Internal Medicine, 1991 - 1993
University of Southern California/LAC+USC Medical CenterInternship, Internal Medicine, 1990 - 1991
Duke University School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1993 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer Start of enrollment: 2012 Dec 01
- Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
- Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer Start of enrollment: 2014 Sep 23
- Join now to see all
Publications & Presentations
PubMed
- Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical Trial.John Shen, Ankush Sachdeva, Tahmineh Romero, John Nikitas, Matthew Rettig, Robert Reiter, Alan Lee, Michael L Steinberg, Luca F Valle, Jeremie Calais, Johannes Czernin...> ;European Urology. 2024 Mar 16
- Systemic and Tumor-directed Therapy for Oligometastatic Prostate Cancer: The SOLAR Phase 2 Trial in De Novo Oligometastatic Prostate Cancer.Nicholas G Nickols, Sonny Tsai, Nathanael Kane, Samantha Tran, Leila Ghayouri, Silvia Diaz-Perez, May Thein, Nancy Anderson-Berman, Jeanie Eason, Amar U Kishan, Michae...> ;European Urology. 2024 Mar 14
- 1 citationsProstate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two R...Nikitas, J., Ong, W., Carrier, N., Romero, T., Millar, J., Steinberg, M., Rettig, M., Boutros, P., Reiter, R., Nickols, N., Valle, L., McGuire, S., Spratt, D., Souhami...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Dec 25
- Join now to see all
Journal Articles
- Functional Profiling of Circulating Tumor Cells with an Integrated Vortex Capture and Single-Cell Protease Activity AssaySteven M Dubinett, Matthew B Rettig, Proceedings of the National Academy of Sciences
Press Mentions
Dr. Matthew Rettig Discusses Precision Medicine in Advanced Prostate CancerMay 16th, 2022- Tool Helps Predict Who Will Respond Best to Targeted Prostate Cancer TherapyJuly 9th, 2021
- Tool Helps Predicts Who Will Respond Best to Targeted Prostate Cancer TherapyJuly 8th, 2021
- Join now to see all
Hospital Affiliations
Ronald Reagan UCLA Medical CenterLos Angeles, California
Greater Los Angeles HCSLos Angeles, California- UCLA Medical Center-Santa MonicaSanta Monica, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
